by
John R. Fischer, Senior Reporter | December 20, 2023
Imbio algorithms include Lung Texture Analysis, for quantifying lung texture to identify interstitial lung disease and other fibrotic conditions; RV/LV, for identifying increased RV/LV diameter ratio, a sign of short-term mortality and adverse clinical events in patients with various pulmonary vascular diseases; and Airway Analysis, for accurate, repeatable airway measurements.
Additionally, it offers lung density analysis algorithms for detecting signs of emphysema, COPD, consolidation, ground glass, COVID-19, and pneumonia. Certain applications like Lung Density Analysis Inspiration include Imbio Noise Reduction Technology (NRT) to aid quantification and visualization of low-dose scans in cases of emphysema and COPD. The company also has an algorithm for checking calcium build-up in the heart’s arteries.
Ad Statistics
Times Displayed: 194156
Times Visited: 5654 For those who need to move fast and expand clinical capabilities -- and would love new equipment -- the uCT 550 Advance offers a new fully configured 80-slice CT in up to 2 weeks with routine maintenance and parts and Software Upgrades for Life™ included.
Invenshure, a venture studio, has spent years building up the company’s portfolio, which includes its XV Scanner. Imbio’s Software as a Service delivery model enables providers to generate XV LVAS and CT LVAS reports from this scanner or existing hospital equipment.
According to Danny Cunagin, chairman of Imbio and co-CEO of Invenshure, the combined platform will “maximize patient impact and shareholder value.”
The companies did not disclose a completion date for the acquisition.
Back to HCB News
